Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.

被引：0
|
作者：
She, Q.-B.
Chandarlapaty, S.
Ye, Q.
Lobo, J.
Haskell, K. M.
Leander, K. R.
DeFeo-Jones, D.
Huber, H. E.
Rosen, N.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Merck Res Labs, West Point, PA USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：222S / 222S
页数：1
相关论文
共 50 条
  • [1] Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
    She, Qing-Bai
    Chandarlapaty, Sarat
    Ye, Qing
    Lobo, Jose
    Haskell, Kathleen M.
    Leander, Karen R.
    DeFeo-Jones, Deborah
    Huber, Hans E.
    Rosen, Neal
    PLOS ONE, 2008, 3 (08):
  • [2] Breast tumor cells with MK mutation or HER2 amplification are selectively dependent on Akt signaling
    She, Qing-Bai
    Chandarlapaty, Sarat
    Ye, Qing
    Lobo, Jose
    Haskell, Kathleen
    Leander, Karen
    DeFeo-Jones, Deborah
    Huber, Hans
    Rosen, Neal
    CANCER RESEARCH, 2009, 69
  • [3] HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3
    Ruiz-Saenz, Ana
    Dreyer, Courtney
    Campbell, Marcia R.
    Steri, Veronica
    Gulizia, Nate
    Moasser, Mark M.
    CANCER RESEARCH, 2018, 78 (13) : 3645 - 3658
  • [4] A Mechanistic Logic for Dual Targeting of HER2 and PI3K/AKT/mTOR Signaling in HER2 Amplified Breast Cancer
    Chandarlapaty, S.
    Rodrik-Outmezguine, V.
    Scaltriti, M. Maurizio
    Sakr, R.
    Will, M.
    Giri, D.
    Hudis, C.
    Baselga, J.
    King, T.
    Rosen, N.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 127 - 127
  • [5] HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review
    Pan, Linghui
    Li, Jinling
    Xu, Qi
    Gao, Zili
    Yang, Mao
    Wu, Xiaoping
    Li, Xuesen
    MEDICINE, 2024, 103 (24) : e38508
  • [6] Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2/PI3K/Akt Signaling Pathway
    Kuo, Han-Peng
    Chuang, Tzu-Chao
    Yeh, Ming-Han
    Hsu, Shih-Chung
    Way, Tzong-Der
    Chen, Po-Yuan
    Wang, Shan-Shue
    Chang, Yung-Hsien
    Kao, Ming-Ching
    Liu, Jah-Yao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2011, 59 (15) : 8216 - 8224
  • [7] Crosstalk between breast cancer cells and bone marrow endothelium require the engagement of PI3K/Akt signaling.
    Brandao, JG
    Barata, JT
    Nunes, R
    Nadler, LM
    Cardoso, AA
    BLOOD, 2004, 104 (11) : 366A - 366A
  • [8] The role of Her2 and other oncogenes of the PI3K/AKT pathway in mitochondria
    Rohlenova, Katerina
    Neuzil, Jiri
    Rohlena, Jakub
    BIOLOGICAL CHEMISTRY, 2016, 397 (07) : 607 - 615
  • [9] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [10] Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
    Faber, Anthony C.
    Li, Danan
    Song, YoungChul
    Liang, Mei-Chih
    Yeap, Beow Y.
    Bronson, Roderick T.
    Lifshits, Eugene
    Chen, Zhao
    Maira, Sauveur-Michel
    Garcia-Echeverria, Carlos
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (46) : 19503 - 19508
12345